EVALUATION OF ANTIMICROBIAL ACTIVITY OF ASAFOETIDA
HTML Full TextEVALUATION OF ANTIMICROBIAL ACTIVITY OF ASAFOETIDA
- D. Patil*, S. Shinde, P. Kandpile and A. S. Jain
Shri. D. D. Vispute College of Pharmacy and Research center, New Panvel, Maharashtra, India
ABSTRACT: This study was carried out with the objective of the antibacterial and antifungal activity of chloroform, ethyl acetate, ethanol, methanol and aqueous extracts of Asafoetida. Antibacterial activity was carried out against Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumonia, Escherichia coli and the antifungal activity was evaluated against Aspergillus niger, Candida albicans. The testing was done by well diffusion method and evaluation was done by detecting zone of inhibition (in mm) and minimum inhibitory concentration (MIC). Studies were perfomed with two different concentrations of all extracts (2 mg/ml and 4 mg/ml). Zone of inhibition were compared with standards like Ciprofloxacin (0.1 mg/ml) and Fluconazole (0.1 mg/ml). The results showed that ethyl acetate, ethanol, and methanol extract has significant antimicrobial activity and highest activity was reported with methanolic extract. The minimum inhibitory concentration of methanolic extract, ethanolic extract and ethyl acetate extract against most of the test microorganisms were 1 mg/ml, 1 mg/ml, 2 mg/ml respectively
Keywords:
|
Asafoetida, Antibacterial activity, Antifungal activity
INTRODUCTION: Antibiotics provide the main basis for the therapy of microbial (bacterial and fungal) infections. Since the discovery of these antibiotics and their uses as chemotherapeutic agents there was a belief in the medical fraternity that this would lead to the eventual eradication of infectious diseases. However, Overuse of antibiotics has become the major factor for the emergence and dissemination of multi-drug resistant strains of several groups of microorganisms 1. The worldwide emergence of Escherichia. coli, Klebsiella pneumoniae, Haemophilus and many other ß-lactamase producers has become a major therapeutic problem
Multi-drug resistant strains of E. coli and K. pneumoniae are widely distributed in hospitals and are increasingly being isolated from community acquired infections 2, 3. Candida albicans, also a nosocomial pathogen, has been reported to account for 50-70% cases of invasive candidiasis 4. Alarmingly, the incidence of nosocomial candidemia has risen sharply in the last decade 5.
All this has resulted in severe consequences including increased cost of medicines and mortality of patients. Thus, in light of the evidence of rapid global spread of resistant clinical isolates, the need to find new antimicrobial agents is of paramount importance. However, the past record of rapid, widespread emergence of resistance to newly introduced antimicrobial agents indicates that even new families of antimicrobial agents will have a short life expectancy 6. For this reason, researchers are increasingly turning their attention to herbal products, looking for new leads to develop better drugs against MDR microbe strains 7. In all regions of the World, history shows that medicinal plants have always held an important Place. Plants are rich in a wide variety of secondary metabolites such as tannins, alkaloids and flavonoids, which have been found in vitro to have antimicrobial properties 8. A number of phytotherapy manuals have mentioned various medicinal plants for treating infectious diseases due to their availability, fewer side effects and reduced toxicity 9. There are several reports on the antimicrobial activity of different herbal extracts 10-12.
Many plants have been found to cure urinary tract infections, gastrointestinal disorders, respiratory diseases and cutaneous infections 13, 14. According to the WHO, medicinal plants would be the best source for obtaining variety of drugs 15. These evidences contribute to support and quantify the importance of screening natural products. The aim of the present study was to investigate the antibacterial and antifungal activity of different extracts of Asafoetida against different microbial strains.
Asafoetida: Asafoetida or asafetida is the dried latex (Oleogumresin) exuded from the rhizome or tap root of several species of Ferula.
- Ferula assa-foetida
- Ferula caspica
- Ferula communis
- Ferula conocaula
- Ferula foetida
Asafoetida
Phytochemistry
Asafoetida comprises of resin (40 to 65%), gum (20 to 25%) and volatile oil (4 to 20%).
The resin portion of asafoetida consist asaresinotannol as its key constituents in the free or combined form as esters of ferulic acid. Galbanic acid is also one of the widely present sesquiterpene in resin portion of the drug. One more key constituent of asafoetida is umbelliferone. The gum fraction consists mostly of glucose, galactose, 1- arabinose, rhamnose and glucuronic acid 16, 17. The oil of asafoetida is usually obtained by steam distillation of oleo-gum resin. The oil comprises mostly of volatile polysulphides. Apart from the volatile polysulphides there are numerous terpenoidal compounds present additionally 18, 19.
Apart from the aforesaid sesquiterpenes and the volatile polysulphides the various other phytoconstituents are the diterpenes like the 7-oxocallitrisic acid, picealactone C, 15-hydroxy-6-en-dehydroabietic acid, various phenolic compounds like vanillin, 3,4-dimethoxycinnamyl-3-(3,4-diacetoxyphenyl) acrylate, acetylenes such as falccarinolone and various other miscellaneous compounds such as oleic acid and β-sitosterol 16, 18, 19.
Sesquiterpene coumarins such as foetidin, 4 methoxycoumarin, colladonin, asafoetidnol A, assafoetidnol B are the constituents present in the roots. Apart from the above mentioned sesquiterpene compounds the roots of Ferula species also consist of a volatile polysulphides derivatives, foetisulphide A and foetisulphideC 19, 20.
MATERIALS AND METHODS:
Plant Material
Asafoetida was collected from local market in Mumbai, Maharashtra. This powder was stored in an air tight container for successive extraction.
Preparation of Extracts
Chloroform, ethyl acetate, ethanol, methanol (95 %) and aqueous extracts of Asafoetida were prepared by maceration method. The powdered plant material (250 g) was repeatedly extracted in a 1000 ml conical flask with 500ml solvents of increasing polarity starting with chloroform. Extraction was carried out at room temperature, filtered and evaporated to dryness under reduced pressure in a rotary evaporator and stored in desiccators for further work. The yield of different extracts prepared with chloroform, ethyl acetate, ethanol, methanol and water were found to be 3.45%, 2.12%, 6.79 %, 8.53% and 11.75% respectively.
Phytochemical screening
A preliminary phytochemical screening of all these extracts was carried out 21.
Determination of antimicrobial activity
Microorganisms
For antibacterial activity-Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumonia, Escherichia coli. For antifungal activity-Aspergillus niger, Candida albicans. These were selected as test microorganisms in the present study.
Culture media
For antibacterial activity- Nutrient agar medium
For antifungal activity-Sabouraud medium
Mediums were procured from HiMedia Chemicals, Mumbai.
Evaluation of antibacterial and antifungal activity 22-25
Antibacterial and antifungal activity
The in vitro antimicrobial activity of different extracts was studied by agar well diffusion method. The antibacterial studies were carried out against Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, in nutrient agar medium. Antifungal studies were carried out against Aspergillus niger, Candida albicans in Sabouraud medium. The medium was sterilized by autoclaving at 120°C (15 lb/in2). 20ml of sterile culture medium was poured into sterile Petri-dishes and allowed to solidify. The Petri dishes were incubated at 37°C for 24 hours to check for sterility. The medium was seeded with the organisms by pour plate method using sterile top agar (4 ml) contained 1 ml culture. In each plate wells of 8 mm diameter were made using a sterile borer. Bacterial concentration of 1×108 CFU/ml was used for antibacterial activity and fungal suspension of 1×106 CFU/ml for antifungal activity. The extracts were freshly reconstituted with dimethyl sulphoxide to 2 mg/ml and 4 mg/ml concentrations. The test samples and the control (0.2 ml) were placed in 8 mm diameter well. Antibacterial assay plates were incubated at 37 ± 1°C for 24 h, whereas antifungal assay plates were incubated at 28 ± 1°C 48 h. Dimethyl sulphoxide (DMSO) was used as solvent control (negative control) and maintained at the same experimental conditions. Standard antibiotics ciprofloxacin (0.1 mg/ml) and Fluconazole (0.1 mg/ml) were used as positive antibacterial and antifungal control respectively. Diameter of the zone of inhibition (in mm) surrounding each well was recorded. The extracts that showed significant antimicrobial activity were subjected to minimum inhibitory concentration (MIC) assay. All experiments were performed in triplicate.
Determination of MIC values:
The MIC of the extracts was determined using two fold serial microdilution method with saline at a final concentration ranging from 4 mg/ml to 0.0312 mg/ml. The tested extracts were added to sterile Muller- Hinton broth in microtiter plates before the diluted bacterial suspension (final inoculums of 1×108 CFU/ml) and (fungal suspension of 1×106 CFU/ml) were added. Each extract was assayed in triplicate. The MIC values were taken as the lowest concentration of the extracts in the well of the microtiter plate that showed no turbidity after incubation at 37 ± 1°C for 24 h for bacteria and at 28 ± 1°C 48 h for fungi. The turbidity of wells in the microtiter plates were interpreted as visible growth of microorganisms.
RESULTS:
Pharmacognostic evaluation showed the presence of various chemical components in different extracts. Data is given in Table 1
TABLE 1: PHYTOCHEMICAL SCREENING
Chemical component | Chloroform extract | Ethyl acetate extract | Ethanol extract | Methanol extract | Aqueous extract |
Alkaloids | + | + | + | + | - |
Tannins | - | + | + | + | - |
Anthraquinones | - | - | - | - | - |
Glycosides | - | + | + | + | - |
Carbohydrates | - | - | + | + | - |
Saponins | - | + | + | + | + |
Flavonoids | - | + | + | + | + |
Terpenoids | + | + | + | - | + |
Proteins | - | + | + | + | - |
Steroids | - | + | - | - | - |
(+) Present; (-) Absent
Antimicrobial activity: It is recorded in terms of zone of inhibition in mm. Table 2 shows value for zone of inhibition for all five extract against all microbial strains.
TABLE 2: ZONE OF INHIBITION FOR DIFFERENT EXTRACTS
Extract | Concentration (mg/ml) | Zone of inhibition (mm)Mean ± SEM | |||||
B.s. | S.a. | E.c. | K.p. | A.n. | C.a. | ||
Chloroform | 2 mg/ml | 08.22±
0.09 |
09.21±
0.04 |
08.42±
0.19 |
08.18±
0.13 |
09.34±
0.12 |
10.65±
0.22 |
4 mg/ml | 09.38±
0.23 |
10.22±
0.08 |
09.22±
0.09 |
08.50±
0.16 |
11.27±
0.22 |
11.40±
0.32 |
|
Ethyl acetate | 2 mg/ml | 12.07±
0.07 |
12.32±
0.09 |
15.27±
0.32 |
12.10±
0.09 |
13.4±
0.11 |
12.37±
0.15 |
4 mg/ml | 13.21±
0.15 |
14.22±
0.12 |
17.14±
0.22 |
14.13±
0.12 |
15.21±
0.14 |
15.37±
0.21 |
|
Ethanol | 2 mg/ml | 15.24±
0.15 |
12.57±
0.12 |
13.12±
0.12 |
14.37±
0.14 |
14.17±
0.13 |
13.15±
0.12 |
4 mg/ml | 17.21±
0.11 |
16.23±
0.12 |
15.13±
0.16 |
16.23±
0.12 |
15.24±
0.21 |
16.27±
0.17 |
|
Methanol | 2 mg/ml | 16.47±
0.14 |
16.37±
0.06 |
16.23±
0.08 |
14.30±
0.21 |
14.24±
0.15 |
15.37±
0.14 |
4 mg/ml | 22.15±
0.24 |
20.11±
0.10 |
19.31±
0.09 |
17.14±
0.16 |
17.15±
0.11 |
20.23±
0.12 |
|
Aqueous | 2 mg/ml | 09.15±
0.06 |
08.36±
0.05 |
- | - | 11.2±
0.09 |
11.85±
0.17 |
4 mg/ml | 11.18±
0.09 |
09.24±
0.10 |
- | - | 13.7±
0.15 |
11.47±
0.15 |
|
Ciprofloxacin | 0.1 mg/ml | 26.21±
0.11 |
24.11±
0.12 |
23.15±
0.24 |
20.21±
0.08 |
NA | NA |
Fluconazole | 0.1 mg/ml | NA | NA | NA | NA | 20.16±
0.09 |
24.21±
0.08 |
DMSO | - | - | - | - | - | - | - |
*Each value is Mean±SEM of 3 assays
NA- not applicable; .B.s.-Bacillus subtilis; S.a.-Staphylococcus aureus; K.p.-Klebsiella pneumonia, E.c.-Escherichia coli; A.n.- Aspergillus
niger; C.a.-Candida albicans.
Determination of MIC values of the extracts
TABLE 3: MIC FOR ETHYL ACETATE EXTRACT
Concentration
(mg/ml) |
Ethyl acetate extract | |||||
B.s. | S.a. | E.c. | K.p. | A.n. | C.a. | |
4 | - | - | - | - | - | - |
2 | - | - | - | - | - | - |
1 | + | + | - | + | + | + |
0.5 | + | + | + | + | + | + |
0.25 | + | + | + | + | + | + |
0.125 | + | + | + | + | + | + |
0.0625 | + | + | + | + | + | + |
0.03125 | + | + | + | + | + | + |
(+)Presence of growth; (-) Absence of growth
TABLE 4: MIC FOR ETHANOL EXTRACT
Concentration
(mg/ml) |
Ethanol extract | |||||
B.s. | S.a. | E.c. | K.p. | A.n. | C.a. | |
4 | - | - | - | - | - | - |
2 | - | - | - | - | - | - |
1 | - | - | - | - | - | - |
0.5 | + | + | + | + | + | + |
0.25 | + | + | + | + | + | + |
0.125 | + | + | + | + | + | + |
0.0625 | + | + | + | + | + | + |
0.03125 | + | + | + | + | + | + |
(+)Presence of growth; (-) Absence of growth
TABLE 5: MIC FOR METHANOL EXTRACT
Concentration
(mg/ml) |
Methanol extract | |||||
B.s. | S.a. | E.c. | K.p. | A.n. | C.a. | |
4 | - | - | - | - | - | - |
2 | - | - | - | - | - | - |
1 | - | - | - | - | - | - |
0.5 | - | - | + | + | + | + |
0.25 | + | + | + | + | + | + |
0.125 | + | + | + | + | + | + |
0.0625 | + | + | + | + | + | + |
0.03125 | + | + | + | + | + | + |
(+) Presence of growth; (-) Absence of growth
DISCUSSIONS: All the extracts showed antimicrobial activity on the some microorganisms under test but ethyl acetate, ethanol and methanol extracts were found to be active against all microorganisms and are more effective, hence subjected to MIC determination. The minimum inhibitory concentration of methanolic extract, ethanolic extract and ethyl acetate extract against most of the test microorganisms were 1 mg/ml, 1 mg/ml, 2 mg/ml respectively. Of the different extracts, the methanol extract displayed the highest antimicrobial activity, as it was evidenced by the highest mean zone of inhibition against maximum of the test microorganism. Preliminary phytochemical screening of the extracts showed presence of flavonoids, glycosides, tannins, alkaloids, terpenoids and polyphenolic compounds.
It has been reported that tannins inhibit many microbial enzymes in raw culture filtrates or in purified forms 26. The astringent property of the tannins is reported to be due to its complexation with enzymes or substrates and metal ions 27, 28. Polyphenolic compounds are known to have antimicrobial activity possibly due to enzyme inhibition in the oxidized forms or through more nonspecific interactions with the proteins. Also various secondary metabolites of plant origin are known to possess antimicrobial activity 29.
CONCLUSIONS: The antimicrobial activity found to increases in the extracts in order of ethyl acetate extract, ethanol extract and methanol extract. From the present investigations, we can conclude that asafoetida possesses significant antimicrobial activity due to presence of various phytoconstituents and it could be a source of new antibiotic compounds. The above antimicrobial activity of asafoetida may be due to the combined
or individual effect of the present phytoconstituents, which can be further confirmed by the extensive studies.
ACKNOWLEDGEMENTS: Authors are thankful to Dr. Ashish Jain, Principal, Shri. D. D. Vispute college of Pharmacy and Research Center for motivation and support and for providing necessary facilities.
REFERENCES:
- Harbottle H, Thakur S, Zhao S and White DG: Genetics of Antimicrobial Resistance. Anim. Biotechnol 2006; 17: 111-124.
- Khan AU and Musharraf A: Plasmid Mediated Multiple Antibiotic Resistances in Proteus mirabilis Isolated from Patients with Urinary Tract Infection. Sci. Mont. 2004; 10: 598-602.
- Akram M, Shahid M and Khan AU: Etiology and Antibiotics Resistance Pattern of Community Acquired Urinary Infections in J N M C Hospital Aligarh India. Clin. Microbiol. Antimicrob. 2007; 6: 4-10.
- Paula CR, Krebs VL, Auler ME, Ruiz LS, Matsumoto FE, Silva EH, Diniz EM and Vaz FA: Nosocomial Infection in Newborns by Pichiaanomala in a Brazilian Intensive Care Unit. Med. Mycol. 2006; 44: 479-484.
- Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW and Hajjeh RA: The Epidemiology of Candidemia in Two United States Cities: Results of a Population Based Active Surveillance. Clin. Infect. Dis. 1999; 29:1164-1170.
- Coates A, Hu Y, Bax R and Page C: The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Discov. 2002; 1: 895-910.
- Braga LC, Leite AAM, Xavier KGS, Takahashi JA, Bemquerer MP, Chartone-Souza E and Nascimento AMA: Synergic interaction between pomegranate extracts and antibiotics against Staphylococcus aureus. Can. J. Microbiol. 2005; 51: 541-547.
- Lewis K and Ausubel FM: Prospects of plant derived antibacterials. Biotechnol. 2006; 24:1504-1507.
- Lee SB, Cha KH, Kim SN, Altantsetseg S, Shatar S, Sarangerel O and Nho CW: The Antimicrobial Activity of Essential Oil from Dracocephalum foetidum Against Pathogenic Microorganisms. J. Microbiol. 2007; 45: 53-57.
- Bonjar S: Evaluation of Antibacterial Properties of Some Medicinal Plants Used in Iran. Ethnopharmacol. 2004; 94: 301-305.
- Islam B, Khan SN, Haque I, Alam M, Mushfiq M and Khan AU: Novel Antinadherence Activity of Mulberry Leaves: Inhibition of Streptococcus mutans Biofilm by 1-Deoxynojirimycin Isolated from Morus alba Antimicrob. Chemother. 2008; 62: 751-757.
- Boer HJ, Kool A, Broberg A, Mziray WR, Hedberg I and Levenfors JJ: Antifungal and Antibacterial Activity of Some Herbal Remedies from Tanzania. J. Ethnopharmacol. 2005; 96: 461-469.
- Brantner A and Grein E: Antibacterial Activity of Plant Extracts Used Externally in Traditional Medicine. J. Ethnopharmacol. 1994; 44: 35-40.
- Somchit MN, Reezal I, Nur IE and Mutalib AR: In vitro Antimicrobial Activity of Ethanol and Water Extracts of Cassia alata. J. Ethnopharmacol. 2003; 84: 1-4.
- Hussein AA, Bozzi B, Correa M, Capson TL, Kursar TA, Coley PD, Solis PN and Gupta MP: Bioactive Constituents from Three Vismia Species Nat. Prod. 2003; 66: 858-860.
- Shah and Seth: Textbook of Pharmacognosy and Phytochemistry. Elsevier, Edition 1, 2010: 319-321.
- Jean Bruneton: Pharmacognosy, Phytochemistry and Medicinal Plants. Lavoisier Publication, Edition 2, 1999: 582.
- Rangari VD: Pharmacognosy and Phytochemistry. Career Publication, Edition 2, Vol. I, 2009: 424-426.
- Iranshahy M and Iranshahi M: Traditional uses, Phytochemistry and Pharmacology of asafoetida (Ferula assa-foetida oleo-gum-resin).J Ethnopharmacol. 2011; 134: 1–10.
- Kajimoto T: Sesquiterpenoid and disulphide derivatives from ferula assa-foetida. Phytochemistry 1989; 28: 1761-1763.
- Khandelwal KR: Practical Pharmacognosy Techniques and Experiments. Nirali Prakashan, Ninth edition 2000.
- Pelczar MJ and Reid JD: Microbiology. Tata McGraw Hill, New Delhi, Edition 5, 1986: 473.
- Mandal SM, Mondal KC and Dey S: Antimicrobial activity of the leaf extracts of Hyptis suaveolens (L.) poit. Ind. J. Pharm. Sci.2007; 4: 568-569.
- Mukherjee PK, Balasubramanian R., Saha K, Saha BP, and Pal M: Antibacterial efficiency of Nelumbo nucifera (Nymphaeaceae) rhizomes extract. Indian Drugs 1995; 32: 274–276.
- Jones RN, Barry AL and Gavan TL: Microdilution and macrodilution broth procedures. In: Lennette EH, Balows A, Hausler WJ, Editors, Manual of Clinical Microbiology, American Society for Microbiology. Washington, DC, Edition 4, 1985: 972–977.
- Jones GA, McAllister TA, Muir AD and Cheng KJ: Effects of sainfoin (Onobrychis viciifolia ) condensed tannins on growth and proteolysis by four strains of ruminal bacteria. Appl. Environ. Microbiol. 1994; 60:1374–1378.
- Mason TL and Wasserman BP: Inactivation of red beet betaglucan synthase by native and oxidized phenolic compounds. Phytochemistry1987; 26: 2197–2202.
- Chung KT, Lu Z and Chou MW: Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. Chem. Toxicol. 1998; 36: 1053–1060.
- Marjorie MC: Plant products as antimicrobial agents. Microbiol. Rev.1999; 12: 564–83.
How to cite this article:
Patil SD, Shinde S, Kandpile P and Jain AS: Evaluation of Antimicrobial Activity of Asafoetida.. Int J Pharm Sci Res 2015; 6(2): 722-27.doi: 10.13040/IJPSR.0975-8232.6 (2).722-27.
All © 2013 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
28
722-727
425KB
1814
English
Ijpsr
S. D. Patil*, S. Shinde, P. Kandpile and A. S. Jain
Shri. D. D. Vispute College of Pharmacy and Research center, New Panvel, Maharashtra, India
sushamapatil24@gmail.com
27 June, 2014
28 August, 2014
29 October, 2014
http://dx.doi.org/10.13040/IJPSR.0975-8232.6(2).722-27
01 February, 2015